Global Quadrivalent Influenza Virus Split Vaccine Market Growth 2026-2032
The global Quadrivalent Influenza Virus Split Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Quadrivalent influenza virus split vaccine refers to an inactivated split influenza vaccine whose vaccine components include A (H3N2) subtype, A (H1N1) pdm09 subtype, and type B Victoria and Yamagata lines.
United States market for Quadrivalent Influenza Virus Split Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Quadrivalent Influenza Virus Split Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Quadrivalent Influenza Virus Split Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Quadrivalent Influenza Virus Split Vaccine players cover Hualan Biological Engineering, ADIMMUNE Corporation, Jiangsu GDK Biotechnology, Shanghai Institute Of Biological Products, Changchun Lnstitute of Biological Products Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Quadrivalent Influenza Virus Split Vaccine Industry Forecast” looks at past sales and reviews total world Quadrivalent Influenza Virus Split Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Quadrivalent Influenza Virus Split Vaccine sales for 2026 through 2032. With Quadrivalent Influenza Virus Split Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quadrivalent Influenza Virus Split Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Quadrivalent Influenza Virus Split Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Quadrivalent Influenza Virus Split Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Quadrivalent Influenza Virus Split Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quadrivalent Influenza Virus Split Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quadrivalent Influenza Virus Split Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Quadrivalent Influenza Virus Split Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Quadrivalent influenza virus split vaccine refers to an inactivated split influenza vaccine whose vaccine components include A (H3N2) subtype, A (H1N1) pdm09 subtype, and type B Victoria and Yamagata lines.
United States market for Quadrivalent Influenza Virus Split Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Quadrivalent Influenza Virus Split Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Quadrivalent Influenza Virus Split Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Quadrivalent Influenza Virus Split Vaccine players cover Hualan Biological Engineering, ADIMMUNE Corporation, Jiangsu GDK Biotechnology, Shanghai Institute Of Biological Products, Changchun Lnstitute of Biological Products Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Quadrivalent Influenza Virus Split Vaccine Industry Forecast” looks at past sales and reviews total world Quadrivalent Influenza Virus Split Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Quadrivalent Influenza Virus Split Vaccine sales for 2026 through 2032. With Quadrivalent Influenza Virus Split Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Quadrivalent Influenza Virus Split Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Quadrivalent Influenza Virus Split Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Quadrivalent Influenza Virus Split Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Quadrivalent Influenza Virus Split Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Quadrivalent Influenza Virus Split Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Quadrivalent Influenza Virus Split Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Quadrivalent Influenza Virus Split Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 0.5mL/Tube
- Others
- Influenza A Virus Prevention
- Influenza B Virus Prevention
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hualan Biological Engineering
- ADIMMUNE Corporation
- Jiangsu GDK Biotechnology
- Shanghai Institute Of Biological Products
- Changchun Lnstitute of Biological Products Co., Ltd.
- Wuhan Institute of Biological Products Co., Ltd.
- Sinovac Biotech
- Chongqing Zhifei Biological Products
- Sanofi Pasteur
- What is the 10-year outlook for the global Quadrivalent Influenza Virus Split Vaccine market?
- What factors are driving Quadrivalent Influenza Virus Split Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Quadrivalent Influenza Virus Split Vaccine market opportunities vary by end market size?
- How does Quadrivalent Influenza Virus Split Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Quadrivalent Influenza Virus Split Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Quadrivalent Influenza Virus Split Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Quadrivalent Influenza Virus Split Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Quadrivalent Influenza Virus Split Vaccine Segment by Type
2.2.1 0.5mL/Tube
2.2.2 Others
2.2.3 Quadrivalent Influenza Virus Split Vaccine Sales by Type
2.2.3.1 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Type (2021-2026)
2.3 Quadrivalent Influenza Virus Split Vaccine Segment by Application
2.3.1 Influenza A Virus Prevention
2.3.2 Influenza B Virus Prevention
2.3.3 Quadrivalent Influenza Virus Split Vaccine Sales by Application
2.3.3.1 Global Quadrivalent Influenza Virus Split Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Quadrivalent Influenza Virus Split Vaccine Breakdown Data by Company
3.1.1 Global Quadrivalent Influenza Virus Split Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Quadrivalent Influenza Virus Split Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Company (2021-2026)
3.2.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Company
3.4 Key Manufacturers Quadrivalent Influenza Virus Split Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Quadrivalent Influenza Virus Split Vaccine Product Location Distribution
3.4.2 Players Quadrivalent Influenza Virus Split Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR QUADRIVALENT INFLUENZA VIRUS SPLIT VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Quadrivalent Influenza Virus Split Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Quadrivalent Influenza Virus Split Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Quadrivalent Influenza Virus Split Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Quadrivalent Influenza Virus Split Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Quadrivalent Influenza Virus Split Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Quadrivalent Influenza Virus Split Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Quadrivalent Influenza Virus Split Vaccine Sales Growth
4.4 APAC Quadrivalent Influenza Virus Split Vaccine Sales Growth
4.5 Europe Quadrivalent Influenza Virus Split Vaccine Sales Growth
4.6 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Growth
5 AMERICAS
5.1 Americas Quadrivalent Influenza Virus Split Vaccine Sales by Country
5.1.1 Americas Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026)
5.1.2 Americas Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026)
5.2 Americas Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026)
5.3 Americas Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quadrivalent Influenza Virus Split Vaccine Sales by Region
6.1.1 APAC Quadrivalent Influenza Virus Split Vaccine Sales by Region (2021-2026)
6.1.2 APAC Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2021-2026)
6.2 APAC Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026)
6.3 APAC Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Quadrivalent Influenza Virus Split Vaccine by Country
7.1.1 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026)
7.1.2 Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026)
7.2 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026)
7.3 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine by Country
8.1.1 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Quadrivalent Influenza Virus Split Vaccine
10.3 Manufacturing Process Analysis of Quadrivalent Influenza Virus Split Vaccine
10.4 Industry Chain Structure of Quadrivalent Influenza Virus Split Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Quadrivalent Influenza Virus Split Vaccine Distributors
11.3 Quadrivalent Influenza Virus Split Vaccine Customer
12 WORLD FORECAST REVIEW FOR QUADRIVALENT INFLUENZA VIRUS SPLIT VACCINE BY GEOGRAPHIC REGION
12.1 Global Quadrivalent Influenza Virus Split Vaccine Market Size Forecast by Region
12.1.1 Global Quadrivalent Influenza Virus Split Vaccine Forecast by Region (2027-2032)
12.1.2 Global Quadrivalent Influenza Virus Split Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Quadrivalent Influenza Virus Split Vaccine Forecast by Type (2027-2032)
12.7 Global Quadrivalent Influenza Virus Split Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hualan Biological Engineering
13.1.1 Hualan Biological Engineering Company Information
13.1.2 Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.1.3 Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hualan Biological Engineering Main Business Overview
13.1.5 Hualan Biological Engineering Latest Developments
13.2 ADIMMUNE Corporation
13.2.1 ADIMMUNE Corporation Company Information
13.2.2 ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.2.3 ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 ADIMMUNE Corporation Main Business Overview
13.2.5 ADIMMUNE Corporation Latest Developments
13.3 Jiangsu GDK Biotechnology
13.3.1 Jiangsu GDK Biotechnology Company Information
13.3.2 Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.3.3 Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Jiangsu GDK Biotechnology Main Business Overview
13.3.5 Jiangsu GDK Biotechnology Latest Developments
13.4 Shanghai Institute Of Biological Products
13.4.1 Shanghai Institute Of Biological Products Company Information
13.4.2 Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.4.3 Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Institute Of Biological Products Main Business Overview
13.4.5 Shanghai Institute Of Biological Products Latest Developments
13.5 Changchun Lnstitute of Biological Products Co., Ltd.
13.5.1 Changchun Lnstitute of Biological Products Co., Ltd. Company Information
13.5.2 Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.5.3 Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Changchun Lnstitute of Biological Products Co., Ltd. Main Business Overview
13.5.5 Changchun Lnstitute of Biological Products Co., Ltd. Latest Developments
13.6 Wuhan Institute of Biological Products Co., Ltd.
13.6.1 Wuhan Institute of Biological Products Co., Ltd. Company Information
13.6.2 Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.6.3 Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Wuhan Institute of Biological Products Co., Ltd. Main Business Overview
13.6.5 Wuhan Institute of Biological Products Co., Ltd. Latest Developments
13.7 Sinovac Biotech
13.7.1 Sinovac Biotech Company Information
13.7.2 Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.7.3 Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sinovac Biotech Main Business Overview
13.7.5 Sinovac Biotech Latest Developments
13.8 Chongqing Zhifei Biological Products
13.8.1 Chongqing Zhifei Biological Products Company Information
13.8.2 Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.8.3 Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chongqing Zhifei Biological Products Main Business Overview
13.8.5 Chongqing Zhifei Biological Products Latest Developments
13.9 Sanofi Pasteur
13.9.1 Sanofi Pasteur Company Information
13.9.2 Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.9.3 Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sanofi Pasteur Main Business Overview
13.9.5 Sanofi Pasteur Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Quadrivalent Influenza Virus Split Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Quadrivalent Influenza Virus Split Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Quadrivalent Influenza Virus Split Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Quadrivalent Influenza Virus Split Vaccine Segment by Type
2.2.1 0.5mL/Tube
2.2.2 Others
2.2.3 Quadrivalent Influenza Virus Split Vaccine Sales by Type
2.2.3.1 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Type (2021-2026)
2.3 Quadrivalent Influenza Virus Split Vaccine Segment by Application
2.3.1 Influenza A Virus Prevention
2.3.2 Influenza B Virus Prevention
2.3.3 Quadrivalent Influenza Virus Split Vaccine Sales by Application
2.3.3.1 Global Quadrivalent Influenza Virus Split Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Quadrivalent Influenza Virus Split Vaccine Breakdown Data by Company
3.1.1 Global Quadrivalent Influenza Virus Split Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Quadrivalent Influenza Virus Split Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Company (2021-2026)
3.2.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Company
3.4 Key Manufacturers Quadrivalent Influenza Virus Split Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Quadrivalent Influenza Virus Split Vaccine Product Location Distribution
3.4.2 Players Quadrivalent Influenza Virus Split Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR QUADRIVALENT INFLUENZA VIRUS SPLIT VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Quadrivalent Influenza Virus Split Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Quadrivalent Influenza Virus Split Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Quadrivalent Influenza Virus Split Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Quadrivalent Influenza Virus Split Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Quadrivalent Influenza Virus Split Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Quadrivalent Influenza Virus Split Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Quadrivalent Influenza Virus Split Vaccine Sales Growth
4.4 APAC Quadrivalent Influenza Virus Split Vaccine Sales Growth
4.5 Europe Quadrivalent Influenza Virus Split Vaccine Sales Growth
4.6 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Growth
5 AMERICAS
5.1 Americas Quadrivalent Influenza Virus Split Vaccine Sales by Country
5.1.1 Americas Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026)
5.1.2 Americas Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026)
5.2 Americas Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026)
5.3 Americas Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Quadrivalent Influenza Virus Split Vaccine Sales by Region
6.1.1 APAC Quadrivalent Influenza Virus Split Vaccine Sales by Region (2021-2026)
6.1.2 APAC Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2021-2026)
6.2 APAC Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026)
6.3 APAC Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Quadrivalent Influenza Virus Split Vaccine by Country
7.1.1 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026)
7.1.2 Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026)
7.2 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026)
7.3 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine by Country
8.1.1 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Quadrivalent Influenza Virus Split Vaccine
10.3 Manufacturing Process Analysis of Quadrivalent Influenza Virus Split Vaccine
10.4 Industry Chain Structure of Quadrivalent Influenza Virus Split Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Quadrivalent Influenza Virus Split Vaccine Distributors
11.3 Quadrivalent Influenza Virus Split Vaccine Customer
12 WORLD FORECAST REVIEW FOR QUADRIVALENT INFLUENZA VIRUS SPLIT VACCINE BY GEOGRAPHIC REGION
12.1 Global Quadrivalent Influenza Virus Split Vaccine Market Size Forecast by Region
12.1.1 Global Quadrivalent Influenza Virus Split Vaccine Forecast by Region (2027-2032)
12.1.2 Global Quadrivalent Influenza Virus Split Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Quadrivalent Influenza Virus Split Vaccine Forecast by Type (2027-2032)
12.7 Global Quadrivalent Influenza Virus Split Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Hualan Biological Engineering
13.1.1 Hualan Biological Engineering Company Information
13.1.2 Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.1.3 Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Hualan Biological Engineering Main Business Overview
13.1.5 Hualan Biological Engineering Latest Developments
13.2 ADIMMUNE Corporation
13.2.1 ADIMMUNE Corporation Company Information
13.2.2 ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.2.3 ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 ADIMMUNE Corporation Main Business Overview
13.2.5 ADIMMUNE Corporation Latest Developments
13.3 Jiangsu GDK Biotechnology
13.3.1 Jiangsu GDK Biotechnology Company Information
13.3.2 Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.3.3 Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Jiangsu GDK Biotechnology Main Business Overview
13.3.5 Jiangsu GDK Biotechnology Latest Developments
13.4 Shanghai Institute Of Biological Products
13.4.1 Shanghai Institute Of Biological Products Company Information
13.4.2 Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.4.3 Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Shanghai Institute Of Biological Products Main Business Overview
13.4.5 Shanghai Institute Of Biological Products Latest Developments
13.5 Changchun Lnstitute of Biological Products Co., Ltd.
13.5.1 Changchun Lnstitute of Biological Products Co., Ltd. Company Information
13.5.2 Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.5.3 Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Changchun Lnstitute of Biological Products Co., Ltd. Main Business Overview
13.5.5 Changchun Lnstitute of Biological Products Co., Ltd. Latest Developments
13.6 Wuhan Institute of Biological Products Co., Ltd.
13.6.1 Wuhan Institute of Biological Products Co., Ltd. Company Information
13.6.2 Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.6.3 Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Wuhan Institute of Biological Products Co., Ltd. Main Business Overview
13.6.5 Wuhan Institute of Biological Products Co., Ltd. Latest Developments
13.7 Sinovac Biotech
13.7.1 Sinovac Biotech Company Information
13.7.2 Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.7.3 Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Sinovac Biotech Main Business Overview
13.7.5 Sinovac Biotech Latest Developments
13.8 Chongqing Zhifei Biological Products
13.8.1 Chongqing Zhifei Biological Products Company Information
13.8.2 Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.8.3 Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Chongqing Zhifei Biological Products Main Business Overview
13.8.5 Chongqing Zhifei Biological Products Latest Developments
13.9 Sanofi Pasteur
13.9.1 Sanofi Pasteur Company Information
13.9.2 Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
13.9.3 Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Sanofi Pasteur Main Business Overview
13.9.5 Sanofi Pasteur Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Quadrivalent Influenza Virus Split Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Quadrivalent Influenza Virus Split Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.5mL/Tube
Table 4. Major Players of Others
Table 5. Global Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Quadrivalent Influenza Virus Split Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Quadrivalent Influenza Virus Split Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Quadrivalent Influenza Virus Split Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Quadrivalent Influenza Virus Split Vaccine Producing Area Distribution and Sales Area
Table 21. Players Quadrivalent Influenza Virus Split Vaccine Products Offered
Table 22. Quadrivalent Influenza Virus Split Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Quadrivalent Influenza Virus Split Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Quadrivalent Influenza Virus Split Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Quadrivalent Influenza Virus Split Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Quadrivalent Influenza Virus Split Vaccine
Table 52. Key Market Challenges & Risks of Quadrivalent Influenza Virus Split Vaccine
Table 53. Key Industry Trends of Quadrivalent Influenza Virus Split Vaccine
Table 54. Quadrivalent Influenza Virus Split Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Quadrivalent Influenza Virus Split Vaccine Distributors List
Table 57. Quadrivalent Influenza Virus Split Vaccine Customer List
Table 58. Global Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Quadrivalent Influenza Virus Split Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Quadrivalent Influenza Virus Split Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Hualan Biological Engineering Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 74. Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Hualan Biological Engineering Main Business
Table 76. Hualan Biological Engineering Latest Developments
Table 77. ADIMMUNE Corporation Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 79. ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. ADIMMUNE Corporation Main Business
Table 81. ADIMMUNE Corporation Latest Developments
Table 82. Jiangsu GDK Biotechnology Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 84. Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Jiangsu GDK Biotechnology Main Business
Table 86. Jiangsu GDK Biotechnology Latest Developments
Table 87. Shanghai Institute Of Biological Products Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 89. Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Shanghai Institute Of Biological Products Main Business
Table 91. Shanghai Institute Of Biological Products Latest Developments
Table 92. Changchun Lnstitute of Biological Products Co., Ltd. Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 94. Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Changchun Lnstitute of Biological Products Co., Ltd. Main Business
Table 96. Changchun Lnstitute of Biological Products Co., Ltd. Latest Developments
Table 97. Wuhan Institute of Biological Products Co., Ltd. Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 99. Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Wuhan Institute of Biological Products Co., Ltd. Main Business
Table 101. Wuhan Institute of Biological Products Co., Ltd. Latest Developments
Table 102. Sinovac Biotech Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 104. Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Sinovac Biotech Main Business
Table 106. Sinovac Biotech Latest Developments
Table 107. Chongqing Zhifei Biological Products Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 109. Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Chongqing Zhifei Biological Products Main Business
Table 111. Chongqing Zhifei Biological Products Latest Developments
Table 112. Sanofi Pasteur Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 114. Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Sanofi Pasteur Main Business
Table 116. Sanofi Pasteur Latest Developments
Table 1. Quadrivalent Influenza Virus Split Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Quadrivalent Influenza Virus Split Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.5mL/Tube
Table 4. Major Players of Others
Table 5. Global Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Quadrivalent Influenza Virus Split Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Quadrivalent Influenza Virus Split Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Quadrivalent Influenza Virus Split Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Quadrivalent Influenza Virus Split Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Quadrivalent Influenza Virus Split Vaccine Producing Area Distribution and Sales Area
Table 21. Players Quadrivalent Influenza Virus Split Vaccine Products Offered
Table 22. Quadrivalent Influenza Virus Split Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Quadrivalent Influenza Virus Split Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Quadrivalent Influenza Virus Split Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Quadrivalent Influenza Virus Split Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Quadrivalent Influenza Virus Split Vaccine
Table 52. Key Market Challenges & Risks of Quadrivalent Influenza Virus Split Vaccine
Table 53. Key Industry Trends of Quadrivalent Influenza Virus Split Vaccine
Table 54. Quadrivalent Influenza Virus Split Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Quadrivalent Influenza Virus Split Vaccine Distributors List
Table 57. Quadrivalent Influenza Virus Split Vaccine Customer List
Table 58. Global Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Quadrivalent Influenza Virus Split Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Quadrivalent Influenza Virus Split Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Quadrivalent Influenza Virus Split Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Quadrivalent Influenza Virus Split Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Hualan Biological Engineering Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 74. Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Hualan Biological Engineering Main Business
Table 76. Hualan Biological Engineering Latest Developments
Table 77. ADIMMUNE Corporation Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 79. ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. ADIMMUNE Corporation Main Business
Table 81. ADIMMUNE Corporation Latest Developments
Table 82. Jiangsu GDK Biotechnology Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 84. Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Jiangsu GDK Biotechnology Main Business
Table 86. Jiangsu GDK Biotechnology Latest Developments
Table 87. Shanghai Institute Of Biological Products Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 89. Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Shanghai Institute Of Biological Products Main Business
Table 91. Shanghai Institute Of Biological Products Latest Developments
Table 92. Changchun Lnstitute of Biological Products Co., Ltd. Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 94. Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Changchun Lnstitute of Biological Products Co., Ltd. Main Business
Table 96. Changchun Lnstitute of Biological Products Co., Ltd. Latest Developments
Table 97. Wuhan Institute of Biological Products Co., Ltd. Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 99. Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Wuhan Institute of Biological Products Co., Ltd. Main Business
Table 101. Wuhan Institute of Biological Products Co., Ltd. Latest Developments
Table 102. Sinovac Biotech Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 104. Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Sinovac Biotech Main Business
Table 106. Sinovac Biotech Latest Developments
Table 107. Chongqing Zhifei Biological Products Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 109. Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Chongqing Zhifei Biological Products Main Business
Table 111. Chongqing Zhifei Biological Products Latest Developments
Table 112. Sanofi Pasteur Basic Information, Quadrivalent Influenza Virus Split Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Product Portfolios and Specifications
Table 114. Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Sanofi Pasteur Main Business
Table 116. Sanofi Pasteur Latest Developments
LIST OF FIGURES
Figure 1. Picture of Quadrivalent Influenza Virus Split Vaccine
Figure 2. Quadrivalent Influenza Virus Split Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Quadrivalent Influenza Virus Split Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Quadrivalent Influenza Virus Split Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.5mL/Tube
Figure 12. Product Picture of Others
Figure 13. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type in 2026
Figure 14. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Quadrivalent Influenza Virus Split Vaccine Consumed in Influenza A Virus Prevention
Figure 16. Global Quadrivalent Influenza Virus Split Vaccine Market: Influenza A Virus Prevention (2021-2026) & (K Units)
Figure 17. Quadrivalent Influenza Virus Split Vaccine Consumed in Influenza B Virus Prevention
Figure 18. Global Quadrivalent Influenza Virus Split Vaccine Market: Influenza B Virus Prevention (2021-2026) & (K Units)
Figure 19. Global Quadrivalent Influenza Virus Split Vaccine Sale Market Share by Application (2025)
Figure 20. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application in 2026
Figure 21. Quadrivalent Influenza Virus Split Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Company in 2026
Figure 23. Quadrivalent Influenza Virus Split Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Quadrivalent Influenza Virus Split Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Quadrivalent Influenza Virus Split Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Quadrivalent Influenza Virus Split Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Quadrivalent Influenza Virus Split Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Quadrivalent Influenza Virus Split Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Quadrivalent Influenza Virus Split Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Quadrivalent Influenza Virus Split Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Quadrivalent Influenza Virus Split Vaccine
Figure 73. Industry Chain Structure of Quadrivalent Influenza Virus Split Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Quadrivalent Influenza Virus Split Vaccine
Figure 2. Quadrivalent Influenza Virus Split Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Quadrivalent Influenza Virus Split Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Quadrivalent Influenza Virus Split Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Quadrivalent Influenza Virus Split Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.5mL/Tube
Figure 12. Product Picture of Others
Figure 13. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type in 2026
Figure 14. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Quadrivalent Influenza Virus Split Vaccine Consumed in Influenza A Virus Prevention
Figure 16. Global Quadrivalent Influenza Virus Split Vaccine Market: Influenza A Virus Prevention (2021-2026) & (K Units)
Figure 17. Quadrivalent Influenza Virus Split Vaccine Consumed in Influenza B Virus Prevention
Figure 18. Global Quadrivalent Influenza Virus Split Vaccine Market: Influenza B Virus Prevention (2021-2026) & (K Units)
Figure 19. Global Quadrivalent Influenza Virus Split Vaccine Sale Market Share by Application (2025)
Figure 20. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application in 2026
Figure 21. Quadrivalent Influenza Virus Split Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Company in 2026
Figure 23. Quadrivalent Influenza Virus Split Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Quadrivalent Influenza Virus Split Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Quadrivalent Influenza Virus Split Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Quadrivalent Influenza Virus Split Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Quadrivalent Influenza Virus Split Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Quadrivalent Influenza Virus Split Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Quadrivalent Influenza Virus Split Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Quadrivalent Influenza Virus Split Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Quadrivalent Influenza Virus Split Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Quadrivalent Influenza Virus Split Vaccine
Figure 73. Industry Chain Structure of Quadrivalent Influenza Virus Split Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share Forecast by Application (2027-2032)
